BLUEPRINT MEDICINES - Daily - Technical analysis published on 07/18/2019 (GMT)
- Who voted?
- 301
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Court terme:
Bullish
De fond:
Strongly bullish
Technical indicators
44%
11%
44%
My opinion
Bullish above 86.64 USD
My targets
96.76 USD (+0.45%)
102.95 USD (+6.87%)
My analysis
The basic bullish trend is very strong on BLUEPRINT MEDICINES but the short term shows some signs of running out of steam. However, a purchase could be considered as long as the price remains above 86.64 USD. Crossing the first resistance at 96.76 USD would be a sign of a potential new surge in the price. Buyers would then use the next resistance located at 102.95 USD as an objective. Caution, a return to below 86.64 USD would be a sign of a consolidation phase in the short-term basic trend. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
BLUEPRINT MEDICINES rating 96.33 USD. The price registered an increase of +1.68% on the session with the lowest point at 93.86 USD and the highest point at 96.72 USD. The deviation from the price is +2.63% for the low point and -0.40% for the high point.93.86
96.72
96.33
The Central Gaps scanner detects a bullish opening marking the presence of sellers ahead of buyers at the opening but not sufficiently marked to allow the price to register a quotation gap.
Bearish opening
Type : Bearish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of BLUEPRINT MEDICINES indicates that the overall trend is strongly bullish. 89.29% of the signals given by moving averages are bullish. The slightly bullish signals given by the short-term moving averages indicate this trend is showing signs of running out of steam. An assessment of moving averages reveals a bearish signal that could impact this trend:
Bearish price crossover with Moving Average 20
Type : Bearish
Timeframe : Daily
Technical indicators are slightly bullish. There is therefore considerable uncertainty about the continuation of the increase.
Caution: the Central Indicators scanner currently detects an excess:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Daily
Price is back under the pivot point
Type : Bearish
Timeframe : Daily
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
For a small setback in the very short term, the Central Candlesticks scanner currently notes the presence of this bearish pattern in Japanese candlesticks:
Bearish engulfing lines
Type : Bearish
Timeframe : Daily
ProTrendLines
S3
S2
S1
R1
R2
Price
S3 | S2 | S1 | Price | R1 | R2 | |
---|---|---|---|---|---|---|
ProTrendLines | 59.37 | 73.74 | 86.64 | 96.33 | 96.76 | 102.95 |
Change (%) | -38.37% | -23.45% | -10.06% | - | +0.45% | +6.87% |
Change | -36.96 | -22.59 | -9.69 | - | +0.43 | +6.62 |
Level | Intermediate | Major | Major | - | Major | Intermediate |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 92.73 | 93.72 | 94.23 | 95.22 | 95.73 | 96.72 | 97.23 |
Camarilla | 94.33 | 94.47 | 94.60 | 94.74 | 94.88 | 95.02 | 95.15 |
Woodie | 92.49 | 93.60 | 93.99 | 95.10 | 95.49 | 96.60 | 96.99 |
Fibonacci | 93.72 | 94.29 | 94.65 | 95.22 | 95.79 | 96.15 | 96.72 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 85.82 | 89.20 | 92.09 | 95.47 | 98.36 | 101.74 | 104.63 |
Camarilla | 93.27 | 93.84 | 94.42 | 94.99 | 95.57 | 96.14 | 96.71 |
Woodie | 85.59 | 89.08 | 91.86 | 95.35 | 98.13 | 101.62 | 104.40 |
Fibonacci | 89.20 | 91.59 | 93.07 | 95.47 | 97.86 | 99.34 | 101.74 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 40.56 | 53.88 | 74.11 | 87.43 | 107.66 | 120.98 | 141.21 |
Camarilla | 85.10 | 88.18 | 91.26 | 94.33 | 97.41 | 100.48 | 103.56 |
Woodie | 44.01 | 55.61 | 77.56 | 89.16 | 111.11 | 122.71 | 144.66 |
Fibonacci | 53.88 | 66.70 | 74.62 | 87.43 | 100.25 | 108.17 | 120.98 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
RSI (14): | 57.80 | |
MACD (12,26,9): | 2.1700 | |
Directional Movement: | 1.83 | |
AROON (14): | 64.29 | |
DEMA (21): | 97.39 | |
Parabolic SAR (0,02-0,02-0,2): | 93.10 | |
Elder Ray (13): | 0.13 | |
Super Trend (3,10): | 87.45 | |
Zig ZAG (10): | 96.33 | |
VORTEX (21): | 0.9800 | |
Stochastique (14,3,5): | 64.79 | |
TEMA (21): | 96.88 | |
Williams %R (14): | -29.74 | |
Chande Momentum Oscillator (20): | 2.00 | |
Repulse (5,40,3): | 1.8600 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.4600 | |
Courbe Coppock: | 4.31 |
MA7: | 95.58 | |
MA20: | 95.08 | |
MA50: | 87.56 | |
MA100: | 83.94 | |
MAexp7: | 95.58 | |
MAexp20: | 94.14 | |
MAexp50: | 89.37 | |
MAexp100: | 84.03 | |
Price / MA7: | +0.78% | |
Price / MA20: | +1.31% | |
Price / MA50: | +10.02% | |
Price / MA100: | +14.76% | |
Price / MAexp7: | +0.78% | |
Price / MAexp20: | +2.33% | |
Price / MAexp50: | +7.79% | |
Price / MAexp100: | +14.64% |
News
Don"t forget to follow the news on BLUEPRINT MEDICINES. At the time of publication of this analysis, the latest news was as follows:
- Blueprint Medicines Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress
- Blueprint Medicines Submits New Drug Application to U.S. Food and Drug Administration for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
- Blueprint Medicines' Highly Selective RET Inhibitor BLU-667 Shows Durable Anti-Tumor Activity in Patients with RET-Altered Cancers in Updated ARROW Trial Data Presented at ASCO 2019
- Blueprint Medicines to Present at Upcoming Investor Conferences in June
- Blueprint Medicines Announces Data Presentations at ASCO and EHA Meetings from Registration-Enabling Clinical Trials of Avapritinib and BLU-667 Across Multiple Patient Populations
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis BLUEPRINT MEDICINES - Daily